echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: Single-dose Ad26.COV2.S vaccine phase III clinical effect is gratifying, and its preventive effect against South African variants exceeds 50%

    NEJM: Single-dose Ad26.COV2.S vaccine phase III clinical effect is gratifying, and its preventive effect against South African variants exceeds 50%

    • Last Update: 2021-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Ad26.


    Infection Prevention Researchers recently announced the results of the Phase III study of the Ad26.


    In this multi-country, randomized, double-blind, placebo-controlled Phase III clinical study, adult participants randomly receive a single dose of Ad26.


    Coronavirus disease

    In the analysis of the protocol, 19,630 participants who were not infected with new coronary pneumonia at baseline were vaccinated with the Ad26.


    At least 14 days after vaccination, the preventive effect of Ad26.


    A single dose of Ad26.


    A single dose of Ad26.


    Original source:

    Jerald Sadoff et al.


    Safety and Efficacy of Single-Dose Ad26.
    COV2.
    S Vaccine against Covid-19.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.